BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11786525)

  • 1. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
    Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
    Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation.
    Szabó G; Loganathan S; Merkely B; Groves JT; Karck M; Szabó C; Radovits T
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1443-9. PubMed ID: 22401641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest.
    Szabó G; Buhmann V; Andrási T; Stumpf N; Bährle S; Kékesi V; Hagl S; Szabó C; Juhász-Nagy A
    J Thorac Cardiovasc Surg; 2003 Sep; 126(3):651-8. PubMed ID: 14502135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inosine on reperfusion injury after heart transplantation.
    Szabó G; Stumpf N; Radovits T; Sonnenberg K; Gerö D; Hagl S; Szabó C; Bährle S
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):96-102. PubMed ID: 16730445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.
    Szabó G; Soós P; Mandera S; Heger U; Flechtenmacher C; Bährle S; Seres L; Cziráki A; Gries A; Zsengellér Z; Vahl CF; Hagl S; Szabó C
    Shock; 2004 May; 21(5):426-32. PubMed ID: 15087818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
    Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
    Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
    Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
    Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure.
    Pacher P; Liaudet L; Mabley Jg; Komjáti K; Szabó C
    J Am Coll Cardiol; 2002 Sep; 40(5):1006-16. PubMed ID: 12225730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
    Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
    Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
    Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation.
    Szabó G; Soós P; Heger U; Flechtenmacher C; Bährle S; Zsengellér Z; Szabó C; Hagl S
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):226-34. PubMed ID: 15691675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.
    Faro R; Toyoda Y; McCully JD; Jagtap P; Szabo E; Virag L; Bianchi C; Levitsky S; Szabo C; Sellke FW
    Ann Thorac Surg; 2002 Feb; 73(2):575-81. PubMed ID: 11845877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase.
    Korkmaz-Icöz S; Radovits T; Loganathan S; Li S; Ruppert M; Benke K; Brlecic P; Szabó C; Karck M; Szabó G
    Eur J Cardiothorac Surg; 2017 May; 51(5):829-835. PubMed ID: 28204209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fingolimod (FTY720) Preserves High Energy Phosphates and Improves Cardiac Function in Heterotopic Heart Transplantation Model.
    Ahmed N; Farooq J; Sadiq S; Meo SA; Jan A; Cheema FH; Faggian G; Rungatscher A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
    Kaplan J; O'Connor M; Hake PW; Zingarelli B
    Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.
    Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats.
    Hatachi G; Tsuchiya T; Miyazaki T; Matsumoto K; Yamasaki N; Okita N; Nanashima A; Higami Y; Nagayasu T
    Transplantation; 2014 Sep; 98(6):618-24. PubMed ID: 25221900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.